These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 10822080

  • 1. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P.
    Thromb Res; 2000 May 15; 98(4):333-42. PubMed ID: 10822080
    [Abstract] [Full Text] [Related]

  • 2. A novel approach to arterial thrombolysis.
    Klement P, Liao P, Bajzar L.
    Blood; 1999 Oct 15; 94(8):2735-43. PubMed ID: 10515877
    [Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 15; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
    Soni H, Sharma A, Bhatt S, Jain MR, Patel PR.
    Pharmacology; 2008 Apr 15; 82(4):304-9. PubMed ID: 18936552
    [Abstract] [Full Text] [Related]

  • 5. Pre-administration of a carboxypeptidase inhibitor enhances tPA-induced thrombolysis in mouse microthrombi: Evidence from intravital imaging analysis.
    Mathews NS, Suzuki Y, Honkura N, Sano H, Iwashita T, Urano T.
    Thromb Res; 2022 Feb 15; 210():78-86. PubMed ID: 35030422
    [Abstract] [Full Text] [Related]

  • 6. Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI).
    Guimarães AH, Barrett-Bergshoeff MM, Criscuoli M, Evangelista S, Rijken DC.
    Thromb Haemost; 2006 Sep 15; 96(3):325-30. PubMed ID: 16953274
    [Abstract] [Full Text] [Related]

  • 7. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D.
    J Am Coll Cardiol; 1992 May 15; 19(6):1350-9. PubMed ID: 1342779
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 15; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 10. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y, Honda Y.
    J Thromb Thrombolysis; 2019 Jul 15; 48(1):103-110. PubMed ID: 30972711
    [Abstract] [Full Text] [Related]

  • 11. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
    Weitz JI, Leslie B, Hirsh J, Klement P.
    J Clin Invest; 1993 Apr 15; 91(4):1343-50. PubMed ID: 7682569
    [Abstract] [Full Text] [Related]

  • 12. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G, Pascucci C, Nenci GG, Mele A, Bürgi R, Heim J.
    Thromb Haemost; 1993 Aug 02; 70(2):294-300. PubMed ID: 8236138
    [Abstract] [Full Text] [Related]

  • 13. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH, Kim P, Nesheim ME.
    J Biol Chem; 2008 Apr 04; 283(14):8863-7. PubMed ID: 18252711
    [Abstract] [Full Text] [Related]

  • 14. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D, Stassen JM, Verstraete M.
    J Clin Invest; 1983 Feb 04; 71(2):368-76. PubMed ID: 6681615
    [Abstract] [Full Text] [Related]

  • 15. Fibrin-specific fibrinolysis induced by recombinant staphylokinase.
    Shishido Y, Matsumoto T, Sakai M, Kaneda N, Sansawa H, Shimura K, Hashimoto S, Yokokura T.
    Biol Pharm Bull; 1994 Aug 04; 17(8):1060-4. PubMed ID: 7820108
    [Abstract] [Full Text] [Related]

  • 16. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.
    Wang X, Smith PL, Hsu MY, Ogletree ML, Schumacher WA.
    J Thromb Haemost; 2006 Feb 04; 4(2):403-10. PubMed ID: 16420573
    [Abstract] [Full Text] [Related]

  • 17. Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI.
    Mutch NJ, Moore NR, Wang E, Booth NA.
    J Thromb Haemost; 2003 Sep 04; 1(9):2000-7. PubMed ID: 12941043
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.
    Mao SS, Holahan MA, Bailey C, Wu G, Colussi D, Carroll SS, Cook JJ.
    Blood Coagul Fibrinolysis; 2005 Sep 04; 16(6):407-15. PubMed ID: 16093731
    [Abstract] [Full Text] [Related]

  • 19. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX, da Cunha V, Vincelette J, Zhao L, Nagashima M, Kawai K, Yuan S, Emayan K, Islam I, Hosoya J, Sullivan ME, Dole WP, Morser J, Buckman BO, Vergona R.
    Thromb Haemost; 2007 Jan 04; 97(1):54-61. PubMed ID: 17200771
    [Abstract] [Full Text] [Related]

  • 20. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis.
    Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM.
    Circulation; 1992 Oct 04; 86(4):1257-64. PubMed ID: 1394932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.